Moderna says FDA delaying review of COVID-19 vaccine for teens | The Hill: Healthcare Policy

The Food and Drug Administration's review for an emergency use authorization of Moderna’s COVID-19 vaccine for adolescents as young as 12 years old is being delayed as the agency takes a deeper look into a possible rare...